Signet Investment Advisory Group’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.49M	Buy	21,600 +25	+0.1%	+$1.73K	0.77%	43
2025 Q1	$1.5M	Hold	21,575	–	–	0.76%	45
2024 Q4	$1.86M	Hold	21,575	–	–	0.95%	38
2024 Q3	$2.57M	Hold	21,575	–	–	1.29%	32
2024 Q2	$3.08M	Sell	21,575 -2,425	-10%	-$346K	1.65%	25
2024 Q1	$3.08M	Hold	24,000	–	–	1.68%	23
2023 Q4	$2.48M	Hold	24,000	–	–	1.49%	29
2023 Q3	$2.18M	Hold	24,000	–	–	1.45%	29
2023 Q2	$1.94M	Sell	24,000 -2,000	-8%	-$162K	1.28%	31
2023 Q1	$2.07M	Sell	26,000 -2,000	-7%	-$159K	1.43%	27
2022 Q4	$1.89M	Hold	28,000	–	–	1.34%	29
2022 Q3	$1.4M	Sell	28,000 -2,000	-7%	-$99.6K	1.08%	36
2022 Q2	$1.67M	Sell	30,000 -4,000	-12%	-$223K	1.16%	35
2022 Q1	$1.89M	Sell	34,000 -2,000	-6%	-$111K	1.14%	33
2021 Q4	$2.02M	Sell	36,000 -4,000	-10%	-$224K	1.15%	32
2021 Q3	$1.92M	Hold	40,000	–	–	1.21%	32
2021 Q2	$1.68M	Hold	40,000	–	–	1.08%	35
2021 Q1	$1.35M	Hold	40,000	–	–	1.04%	35
2020 Q4	$1.4M	Buy	+40,000	New	+$1.4M	1.1%	30
2019 Q4	$1.16M	Hold	40,000	–	–	1.07%	35
2019 Q3	$1.03M	Hold	40,000	–	–	1.05%	35
2019 Q2	$1.02M	Hold	40,000	–	–	1.06%	35
2019 Q1	$1.05M	Hold	40,000	–	–	1.11%	36
2018 Q4	$921K	Buy	+40,000	New	+$921K	1.03%	36